New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy

Table 2 Comparison between the old model and new model developed from the training set

Factors	Old model	Univariate analysis		Multivariate analysis		New model
	Score	HR	P value	HR	P value	Score
Poor PS	2	1.983	< 0.001	2.005	< 0.001	2
No gastrectomy	1	1.046	0.542	-	-	-
Peritoneal metastasis	1	1.355	< 0.001	1.355	< 0.001	1
Bone metastasis	2	1.605	< 0.001	1.651	< 0.001	2
Lung metastasis	1	1.249	0.188	-	-	-
High ALP	1	1.435	< 0.001	1.406	< 0.001	1
Low albumin	1	1.410	< 0.001	1.447	< 0.001	1
High total bilirubin	1	0.965	0.806	-	-	-
High NLR	-	1.445	< 0.001	1.461	< 0.001	1
Poor histology	-	1.104	0.253	-	-	-

HR: Hazard ratio; poor PS: Performance status 2/3; high ALP: Alkaline phosphatase > 120 IU/L; low albumin: Albumin < 3.3 g/dL; high NLR: Neutrophil-lymphocyte ratio ≥ 3.